• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
https://www.onescdvoice.com/wp-content/uploads/2021/10/Caregivers-Summit.jpg
happenings

Inaugural Sickle Cell Caregivers Summit

The Sickle Cell Community Consortium (SC3) is delighted to present our Inaugural Caregiver Summit in partnership with Elle Cole of Cleverly Changing (Coordinator), the Parent-2-Parent Initiative, and sickle cell community patients and caregivers throughout the country. We invite you to join us for two days of engaging dialogue, dynamic speakers and to hear from innovative voices within the sickle cell community.

Attendees will have an opportunity to share information about how they are navigating life with their loved ones. Discuss best practices for hospitalizations and times when intervention is needed. We will deepen connections and build new relationships as we discuss our unique experiences. Each day, we will gather to explore over 11 different sessions.

Date:
November 12 - 14, 2021

 

Nov 14, 2021
https://www.onescdvoice.com/wp-content/uploads/2021/10/MARAC-Alert-SCDAA.jpeg
spotlight

MARAC Advisory Statement: Update About COVID-19 Vaccines

September 24, 2021 — News about COVID-19 continues to move quickly as we weather the pandemic. The Sickle Cell Disease Association of America’s Medical and Research Advisory Committee provides the following updates on vaccination recommendations:

1. Individuals with SCD are now eligible for the third dose of the COVID-19 vaccine. The CDC recommends that people who are immunocompromised or have medical conditions with poor antibody production receive vaccine boosters. One of the eligible conditions is asplenia (no spleen function). Because of the relationship between asplenia and SCD, sickle cell patients are eligible to receive a third dose of the vaccine if they have already received the first two doses.

2. If you have not had the first dose of the vaccine, please do so as soon as possible. Nearly everybody is eligible to receive their first shot. Only children under age 12 or individuals with known allergies to the vaccine ingredients are ineligible. Thousands of individuals with SCD have now had the COVID-19 vaccine. Like the public, many had some side effects that went away after three days. Only a tiny number of individuals experienced sickle cell pain after their shot. A COVID-19 infection poses a great risk for people with SCD. The vaccine is a safe way to reduce that risk. To find a vaccine location near you, visit www.vaccines.gov.

Sep 24, 2021

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close